Skip To Main Content
Hyo Song Kim on Muck Rack

Hyo Song Kim

As seen in: Wiley, MDPI, AHA/ASA Journals
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hyo Song

Contact Hyo Song, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Association Between Automated Coronary Artery Calcium From Routine Chest Computed Tomography Scans and Cardiovascular Risk in Patients With Colorectal or Gastric Cancer | Circulation: Cardiovascular Quality and Outcomes

|
By Subin Kim, Seonji Kim, Hyo Song Kim, Iksung Cho
| AHA/ASA Journals
Get full access to this article View all available purchase options and get full access to this article. Supplemental Material File (circcvqo-2024-011656-s01.pdf) Tables S1–S2 Figure S1–S11 File (circcvqo-2024-011656-s02.pdf) References 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660 2.
Open in Who Shared Issue with article?

Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study | Journal of Clinical Oncology

|
By Hyo Song Kim, In Gyu Hwang, Sun Young Rha, Choong-kun Lee
| brnw.ch
CONTEXT Key Objective To screen multiple targeted agents as second-line treatment for patients with human epidermal growth factor 2 (HER2)–negative advanced gastric cancer (AGC) in a standard-of-care controlled umbrella trial design.
Open in Who Shared Issue with article?

Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer | Journal of Clinical Oncology

|
By Chang Gon Kim, Minkyu Jung, Hyo Song Kim, Choong-kun Lee
| fal.cn
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients with Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution.
Open in Who Shared Issue with article?
See all 5 articles